| pubmed-article:6802441 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:6802441 | lifeskim:mentions | umls-concept:C0012655 | lld:lifeskim |
| pubmed-article:6802441 | lifeskim:mentions | umls-concept:C0014507 | lld:lifeskim |
| pubmed-article:6802441 | lifeskim:mentions | umls-concept:C0027573 | lld:lifeskim |
| pubmed-article:6802441 | lifeskim:mentions | umls-concept:C0032105 | lld:lifeskim |
| pubmed-article:6802441 | lifeskim:mentions | umls-concept:C0021467 | lld:lifeskim |
| pubmed-article:6802441 | lifeskim:mentions | umls-concept:C0370215 | lld:lifeskim |
| pubmed-article:6802441 | lifeskim:mentions | umls-concept:C1979963 | lld:lifeskim |
| pubmed-article:6802441 | lifeskim:mentions | umls-concept:C0021469 | lld:lifeskim |
| pubmed-article:6802441 | lifeskim:mentions | umls-concept:C2003903 | lld:lifeskim |
| pubmed-article:6802441 | lifeskim:mentions | umls-concept:C0936012 | lld:lifeskim |
| pubmed-article:6802441 | lifeskim:mentions | umls-concept:C0439536 | lld:lifeskim |
| pubmed-article:6802441 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:6802441 | pubmed:dateCreated | 1982-6-24 | lld:pubmed |
| pubmed-article:6802441 | pubmed:abstractText | A study was undertaken on the premise that if an increase of 1 microgram/ml in the concentration of vancomycin in Martin-Lewis medium (MLM) could improve inhibition of Gram-positive cocci, then a concomitant increase in the inhibition of gonococci could also occur. Isolates of Neisseria gonorrhoeae that failed to grow on MLM accounted for 18-5% of all positive culture results for gonorrhoea. The incidence of isolates susceptible to vancomycin was 14% and of those susceptible to trimethoprim 2.4%; one isolate was susceptible to both vancomycin and trimethoprim. The antibiotic-susceptible isolates were more frequently isolated from asymptomatic white men. Plasmid analysis showed that the 2.4-megadalton cryptic plasmic was absent in the vancomycin-susceptible isolates. The large proportion of isolates failing to grow on selective MLM has important clinical implications for the diagnosis of gonorrhea. | lld:pubmed |
| pubmed-article:6802441 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6802441 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6802441 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6802441 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6802441 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6802441 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6802441 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6802441 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6802441 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6802441 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6802441 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6802441 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6802441 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6802441 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6802441 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6802441 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6802441 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6802441 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6802441 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6802441 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6802441 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6802441 | pubmed:language | eng | lld:pubmed |
| pubmed-article:6802441 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6802441 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:6802441 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6802441 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6802441 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6802441 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:6802441 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:6802441 | pubmed:issn | 0007-134X | lld:pubmed |
| pubmed-article:6802441 | pubmed:author | pubmed-author:MillerM AMA | lld:pubmed |
| pubmed-article:6802441 | pubmed:author | pubmed-author:ParkerJ WJW | lld:pubmed |
| pubmed-article:6802441 | pubmed:author | pubmed-author:AndersonPP | lld:pubmed |
| pubmed-article:6802441 | pubmed:author | pubmed-author:RohrerH HHH | lld:pubmed |
| pubmed-article:6802441 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:6802441 | pubmed:volume | 58 | lld:pubmed |
| pubmed-article:6802441 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:6802441 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:6802441 | pubmed:pagination | 96-100 | lld:pubmed |
| pubmed-article:6802441 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
| pubmed-article:6802441 | pubmed:meshHeading | pubmed-meshheading:6802441-... | lld:pubmed |
| pubmed-article:6802441 | pubmed:meshHeading | pubmed-meshheading:6802441-... | lld:pubmed |
| pubmed-article:6802441 | pubmed:meshHeading | pubmed-meshheading:6802441-... | lld:pubmed |
| pubmed-article:6802441 | pubmed:meshHeading | pubmed-meshheading:6802441-... | lld:pubmed |
| pubmed-article:6802441 | pubmed:meshHeading | pubmed-meshheading:6802441-... | lld:pubmed |
| pubmed-article:6802441 | pubmed:meshHeading | pubmed-meshheading:6802441-... | lld:pubmed |
| pubmed-article:6802441 | pubmed:meshHeading | pubmed-meshheading:6802441-... | lld:pubmed |
| pubmed-article:6802441 | pubmed:meshHeading | pubmed-meshheading:6802441-... | lld:pubmed |
| pubmed-article:6802441 | pubmed:meshHeading | pubmed-meshheading:6802441-... | lld:pubmed |
| pubmed-article:6802441 | pubmed:meshHeading | pubmed-meshheading:6802441-... | lld:pubmed |
| pubmed-article:6802441 | pubmed:year | 1982 | lld:pubmed |
| pubmed-article:6802441 | pubmed:articleTitle | Inhibition of Neisseria gonorrhoeae isolates by Martin-Lewis medium. Epidemiology, susceptibility profile, and plasma analysis. | lld:pubmed |
| pubmed-article:6802441 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6802441 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6802441 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6802441 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6802441 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6802441 | lld:pubmed |
